Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma

Gillette, Michael A., Satpathy, Shankha, Cao, Song, Dhanasekaran, Saravana M., Vasaikar, Suhas V., Krug, Karsten, Petralia, Francesca, Li, Yize, Liang, Wen-Wei, Reva, Boris, Krek, Azra, Ji, Jiayi, Song, Xiaoyu, Liu, Wenke, Hong, Runyu, Yao, Lijun, Blumenberg, Lili, Savage, Sara R., Wendl, Michael C., Wen, Bo, Li, Kai, Tang, Lauren C., MacMullan, Melanie A., Avanessian, Shayan C., Kane, M. Harry, Newton, Chelsea J., Cornwell, MacIntosh, Kothadia, Ramani B., Ma, Weiping, Yoo, Seungyeul, Mannan, Rahul, Vats, Pankaj, Kumar-Sinha, Chandan, Kawaler, Emily A., Omelchenko, Tatiana, Colaprico, Antonio, Geffen, Yifat, Maruvka, Yosef E., da Veiga Leprevost, Felipe, Wiznerowicz, Maciej, Gümüş, Zeynep H., Veluswamy, Rajwanth R., Hostetter, Galen, Heiman, David I., Wyczalkowski, Matthew A., Hiltke, Tara, Mesri, Mehdi, Kinsinger, Christopher R., Boja, Emily S., Omenn, Gilbert S., Chinnaiyan, Arul M., Rodriguez, Henry, Li, Qing Kay, Jewell, Scott D., Thiagarajan, Mathangi, Getz, Gad, Zhang, Bing, Fenyö, David, Ruggles, Kelly V., Cieslik, Marcin P., Robles, Ana I., Clauser, Karl R., Govindan, Ramaswamy, Wang, Pei, Nesvizhskii, Alexey I., Ding, Li, Mani, D.R., Carr, Steven A., Webster, Alex, Francis, Alicia, Charamut, Alyssa, Paulovich, Amanda G., Perou, Amy M., Godwin, Andrew K., Karnuta, Andrii, Marrero-Oliveras, Annette, Hindenach, Barbara, Pruetz, Barbara, Kubisa, Bartosz, Druker, Brian J., Birger, Chet, Jones, Corbin D., Valley, Dana R., Rohrer, Daniel C., Zhou, Daniel Cui, Chan, Daniel W., Chesla, David, Clark, David J., Rykunov, Dmitry, Tan, Donghui, Ponomareva, Elena V., Duffy, Elizabeth, Burks, Eric J., Schadt, Eric E., Bergstrom, Erik J., Fedorov, Eugene S., Malc, Ewa, Wilson, George D., Chen, Hai-Quan, Krzystek, Halina M., Liu, Hongwei, Culpepper, Houston, Sun, Hua, Zhang, Hui, Day, Jacob, Suh, James, Whiteaker, Jeffrey R., Eschbacher, Jennifer, McGee, John, Ketchum, Karen A., Rodland, Karin D., Robinson, Karna, Hoadley, Katherine A., Suzuki, Kei, Um, Ki Sung, Elburn, Kim, Wang, Liang-Bo, Chen, Lijun, Hannick, Linda, Qi, Liqun, Sokoll, Lori J., Wojtyś, Małgorzata, Domagalski, Marcin J., Gritsenko, Marina A., Beasley, Mary B., Monroe, Matthew E., Ellis, Matthew J., Dyer, Maureen, Burke, Meghan C., Borucki, Melissa, Sun, Meng-Hong, Roehrl, Michael H., Birrer, Michael J., Noble, Michael, Schnaubelt, Michael, Vernon, Michael, Chaikin, Michelle, Krotevich, Mikhail, Khan, Munziba, Selvan, Myvizhi Esai, Roche, Nancy, Edwards, Nathan J., Vatanian, Negin, Potapova, Olga, Grady, Pamela, McGarvey, Peter B., Mieczkowski, Piotr, Hariharan, Pushpa, Madan, Rashna, Thangudu, Ratna R., Smith, Richard D., Welsh, Robert J., Zelt, Robert, Mehra, Rohit, Matteotti, Ronald, Mareedu, Sailaja, Payne, Samuel H., Cottingham, Sandra, Markey, Sanford P., Chugh, Seema, Smith, Shaleigh, Tsang, Shirley, Cai, Shuang, Boca, Simina M., Carter, Sonya, Gabriel, Stacey, De Young, Stephanie, Stein, Stephen E., Shankar, Sunita, Krubit, Tanya, Liu, Tao, Skelly, Tara, Bauer, Thomas, Velvulou, Uma, Ozbek, Umut, Petyuk, Vladislav A., Sovenko, Volodymyr, Bocik, William E., Maggio, William W., Chen, Xi, Shi, Yan, Wu, Yige, Hu, Yingwei, Liao, Yuxing, Zhang, Zhen, Shi, Zhiao·2020·Cell
DOI 10.1016/j.cell.2020.06.013

Cites (260)

Items 201–257 of 257

  1. Increased expression of SOX4 is a biomarker for malignant status and poor prognosis in patients with non-small cell lung cancer
    Dingmiao Wang, Ting Hao, Yang Pan, Xiaowei Qian, Daixing Zhou · 2015 · Molecular and Cellular Biochemistry
  2. Transcriptional Control of the Human High Mobility Group A1 Gene: Basal and Oncogenic Ras-Regulated Expression
    Isabelle Cleynen, Christel Huysmans, Takehiko Sasazuki, Senji Shirasawa, Wim Van de Ven, Kristel Peeters · 2007 · Cancer Research
  3. Molecular and Immunological Evaluation of the Transcription Factor SOX-4 as a Lung Tumor Vaccine Antigen
    Rachel Sharon Friedman, Chaitanya S. Bangur, Eden J. Zasloff, Li-Qun Fan, Tongtong Wang, Yoshihiro Watanabe, Michael D. Kalos · 2004 · The Journal of Immunology
  4. miR-106b-5p promotes renal cell carcinoma aggressiveness and stem-cell-like phenotype by activating Wnt/β-catenin signalling
    Jun Kun Lu, Jinhuan Wei, Zihao Feng, Zhenhua Chen, Yongqian Wang, Yong Huang, Yong Fang, Yanping Liang, Junjie Cen, Yihui Pan et al. · 2017 · Oncotarget
  5. Cancer‐testis gene PIWIL 1 promotes cell proliferation, migration, and invasion in lung adenocarcinoma
    Kaipeng Xie, Kai Zhang, Jing Kong, Cheng Wang, Yayun Gu, Cheng Liang, Tingting Jiang, Na Qin, Ji‐Bin Liu, Xuejiang Guo et al. · 2017 · Cancer Medicine
  6. Co-expression network analysis identified KIF2C in association with progression and prognosis in lung adenocarcinoma
    Yuquan Bai, Lecai Xiong, Minglin Zhu, Zetian Yang, Jinping Zhao, Hexiao Tang · 2019 · Cancer Biomarkers
  7. Localization of cathepsin B in two human lung cancer cell lines.
    Martin Erdel, Günter TREFZ, Eberhard Spieß, S Habermaas, Herbert Spring, Tamara T. Lah, W. Ébert · 1990 · Journal of Histochemistry & Cytochemistry
  8. Programmed death-1 receptor (PD-1) and PD-ligand-1 (PD-L1) expression in non-small cell lung cancer and the immune-suppressive effect of anaerobic glycolysis
    Alexandra N. Giatromanolaki, Ioannis M. Koukourakis, Konstantina Balaska, Achilleas G. Mitrakas, Adrian Llewellyn Harris, Michael Ioannis Koukourakis · 2019 · Medical Oncology
  9. Inhibition of Shp2 suppresses mutant EGFR-induced lung tumors in transgenic mouse model of lung adenocarcinoma
    Valentina E. Schneeberger, Yuan Ren, Noreen Luetteke, Qingling Huang, Liwei Chen, Harshani R. Lawrence, Nicholas J. Lawrence, Eric B. Haura, John M. Koomen, Domenico Coppola et al. · 2015 · Oncotarget
  10. CBX8 exhibits oncogenic properties and serves as a prognostic factor in hepatocellular carcinoma
    Bo Tang, Yu Tian, Yong Liao, Zeming Li, Shuiping Yu, Huizhao Su, Fudi Zhong, Guandou Yuan, Yan Wang, Hongping Yu et al. · 2019 · Cell Death and Disease
  11. Indoleamine 2,3-dioxygenase 1 and programmed cell death-ligand 1 co-expression correlates with aggressive features in lung adenocarcinoma
    Yuka Kozuma, Kazuki Takada, Gouji Toyokawa, Kenichi Kohashi, Mototsugu Shimokawa, Fumihiko Hirai, Tetsuzo Tagawa, Tatsuro Okamoto, Yoshinao Oda, Yoshihiko Maehara · 2018 · European Journal of Cancer
  12. Co-expression of IDO1 and PD-L1 in lung squamous cell carcinoma: Potential targets of novel combination therapy
    Kazuki Takada, Kenichi Kohashi, Mototsugu Shimokawa, Akira Haro, Atsushi Osoegawa, Tetsuzo Tagawa, Takashi Seto, Yoshinao Oda, Yoshihiko Maehara · 2018 · Lung Cancer
  13. Expression, regulation and function of miR-495 in healthy and tumor tissues
    Hongli Chen, Xiaman Wang, Ju Bai, Aili He · 2017 · Oncology Letters
  14. Integrin-linked kinase (ILK) and src homology 2 domain-containing phosphatase 2 (SHP2): Novel targets in EGFR-mutation positive non-small cell lung cancer (NSCLC)
    Niki Karachaliou, Andrés Felipe Cardona, Jillian Wilhelmina Paulina Bracht, Erika Aldeguer, Ana Drozdowskyj, Manuel Fernández-Bruno, Imane CHAIB-OUKADOUR, Jordi Berenguer, Mariacarmela Santarpía, Masaoki Ito et al. · 2018 · EBioMedicine
  15. Pivotal role of dihydrofolate reductase knockdown in the anticancer activity of 2-hydroxyoleic acid
    Victoria Lladó, Silvia Terés, Mónica Higuera, Rafael Álvarez, Maria Antònia Noguera-Salvà, John E. Halver, Pablo V. Escribá, Xavier Busquets · 2009 · Proceedings of the National Academy of Sciences
  16. Prognostic value of HMGB3 expression in patients with non-small cell lung cancer
    Ning Song, Bao Liu, Jianling Wu, Ruifang Zhang, Lin Duan, Wenshu He, Congmin Zhang · 2013 · Tumor Biology
  17. Disruption of Lymphocyte Function and Signaling in CD45–associated Protein–null Mice
    Akio Matsuda, Satoshi Motoya, Shioko Kimura, R McInnis, Abby Maizel, Akiko Takeda · 1998 · The Journal of Experimental Medicine
  18. The Molecular Era of Surfactant Biology
    Jeffrey A. Whitsett · 2014 · Neonatology
  19. Critical Role of Shp2 in Tumor Growth Involving Regulation of c-Myc
    Y. Ren, Zhengming Chen, Lijun Chen, Bingliang Fang, Hla Win-Piazza, Eric B. Haura, John M. Koomen, Jie Wu · 2010 · Genes & Cancer
  20. Myeloid cell signatures in tumor microenvironment predicts therapeutic response in cancer
    Ali S. Arbab, Bhagelu R. Achyut · 2016 · OncoTargets and Therapy
  21. Epithelial adhesion molecules can inhibit HIV-1–specific CD8+ T-cell functions
    Hendrik Streeck, Douglas S. Kwon, Augustine Pyo, Michael Flanders, Mathieu F. Chevalier, Kenneth Law, Boris Dominik Jülg, Kasper Trocha, Jonathan S. Jolin, Melis N. Anahtar et al. · 2011 · Blood
  22. MODMatcher: Multi-Omics Data Matcher for Integrative Genomic Analysis
    Seungyeul Yoo, Tao Huang, Joshua David Campbell, Eunjee Lee, Zhidong Tu, Mark W. Geraci, Charles A. Powell, Eric E. Schadt, Avrum E. Spira, Jun Zhu · 2014 · PLoS Computational Biology
  23. Performance evaluation of DNA copy number segmentation methods
    Morgane Pierre‐Jean, Guillem Rigaill, Pierre Neuvial · 2014 · Briefings in Bioinformatics
  24. Cathepsin B expression and laminin degradation as factors influencing prognosis of surgically treated patients with lung adenocarcinoma.
    Tetsuya Inoue, Teruyoshi Ishida, Kenji Sugio, Keizō Sugimachi · 1994 · PubMed
  25. Inhibition of Rho-associated coiled-coil containing protein kinase enhances the activation of epidermal growth factor receptor in pancreatic cancer cells
    Masanori Nakashima, Seiji Adachi, Ichiro Yasuda, Takahiro Yamauchi, Junji Kawaguchi, Toshimasa Hanamatsu, Takashi Yoshioka, Yukio Okano, Yoshinobu Hirose, Osamu Kozawa et al. · 2011 · Molecular Cancer
  26. Sensitivity to cdk1-inhibition is modulated by p53 status in preclinical models of embryonal tumors
    Melanie Schwermer, Sangkyun Lee, Johannes Köster, Tom Van Maerken, Harald Stephan, Angelika Eggert, Katharina J. Morik, Johannes Hubertus Schulte, Alexander R. Schramm · 2015 · Oncotarget
  27. Lung Adenocarcinoma in Never Smokers: Problems of Primary Prevention from Aspects of Susceptible Genes and Carcinogens
    Isao Okazaki, Shigemi Ishikawa, Wataru Ando, Yasunori Sohara · 2016 · Anticancer Research
  28. Mib1 contributes to persistent directional cell migration by regulating the Ctnnd1-Rac1 pathway
    Takamasa Mizoguchi, Shoko Ikeda, Saori Watanabe, Michiko SUGAWARA, Motoyuki Itoh · 2017 · Proceedings of the National Academy of Sciences
  29. Insights into Impact of DNA Copy Number Alteration and Methylation on the Proteogenomic Landscape of Human Ovarian Cancer via a Multi-omics Integrative Analysis
    Xiaoyu Song, Jiayi Ji, Kevin J. Gleason, Fan Yang, John A. Martignetti, Lin Chen, Pei Wang · 2019 · Molecular & Cellular Proteomics
  30. An Integrated Genome-Wide Approach to Discover Tumor-Specific Antigens as Potential Immunologic and Clinical Targets in Cancer
    Qing-Wen Xu, Wei Zhao, Yue Wang, Maureen A. Sartor, Dong-Mei Han, Jixin Deng, Rakesh Ponnala, Jiang-Ying Yang, Qing-Yun Zhang, Guoqing Liao et al. · 2012 · Cancer Research
  31. Expression of SHP2 and Related Markers in Non–Small Cell Lung Cancer
    Chunlan Tang, Dan Luo, Heping Yang, Qingliang Wang, Rong Zhang, Guoxiang Liu, Xiangdong Zhou · 2013 · Applied immunohistochemistry & molecular morphology
  32. A new method for constructing tumor specific gene co-expression networks based on samples with tumor purity heterogeneity
    Francesca Petralia, Li Wang, Jie Peng, Arthur Yan, Jun Zhu, Pei Wang · 2018 · Bioinformatics
  33. Evaluation of Advanced Precursor Determination for Tandem Mass Tag (TMT)-Based Quantitative Proteomics across Instrument Platforms
    Samuel A. Myers, Susan Klaeger, Shankha Satpathy, Rosa Viner, Jae Hyuk Choi, John C. Rogers, Karl R. Clauser, Namrata D. Udeshi, Steven A. Carr · 2018 · Journal of Proteome Research
  34. Rare SP‐A alleles and the SP‐A1‐6A4 allele associate with risk for lung carcinoma
    Carola Seifart, H‐M Lin, Ulf Seifart, Alexandra Plagens, Susan L. DiAngelo, Peter von Wichert, Joanna Floros · 2005 · Clinical Genetics
  35. lincRNA‑p21 inhibits the progression of non‑small cell lung cancer via targeting miR‑17‑5p
    Xiang Ao, Ming Jiang, Jie Zhou, Hongling Liang, Haoming Xia, Gang Chen · 2018 · Oncology Reports
  36. Combined expression of protein disulfide isomerase and endoplasmic reticulum oxidoreductin 1‑α is a poor prognostic marker for non‑small cell lung cancer
    Kyoung Kim, Ae An, Ho Park, Kyu Yun Jang, Woo Moon, Myoung Joo Kang, Yong Chan Lee, Ja Ku, Myoung Ja Chung · 2018 · Oncology Letters
  37. New Method for Joint Network Analysis Reveals Common and Different Coexpression Patterns among Genes and Proteins in Breast Cancer
    Francesca Petralia, Won‐Min Song, Zhidong Tu, Pei Wang · 2016 · Journal of Proteome Research
  38. An EZH2-mediated epigenetic mechanism behind p53-dependent tissue sensitivity to DNA damage
    Gamze Kuser Abali, Lu Gong, Jiawei Yan, Qingqing Liu, Weiqi Zeng, Amanda K. Williamson, Chuan Bian Lim, Mary Ellen Molloy, John B. Little, Lei Haley Huang et al. · 2018 · Proceedings of the National Academy of Sciences
  39. Cathepsin B expression in tumour cells and laminin distribution in pulmonary adenocarcinoma.
    Masahiko Higashiyama, Osamu Doi, Ken Kodama, Hideoki Yokouchi, Ryosuke Tateishi · 1993 · Journal of Clinical Pathology
  40. Role of the novel gene BZW2 in the development of hepatocellular carcinoma
    Xin Jin, Mingmei Liao, Lihua Zhang, Manyi Yang, Jinfeng Zhao · 2019 · Journal of Cellular Physiology
  41. The multifaceted oncogene SND1 in cancer: focus on hepatocellular carcinoma
    Saranya Chidambaranathan Reghupaty, Rachel G. Mendoza, Paul B. Fisher, Devanand Sarkar · 2018 · Hepatoma Research
  42. Impact of Glutathione-S-Transferases (GST) Polymorphisms and Hypermethylation of Relevant Genes on Risk of Prostate Cancer Biochemical Recurrence: A Meta-Analysis
    Rui Chen, Shancheng Ren, Tong Meng, Josephine Aguilar, Yinghao Sun · 2013 · PLoS ONE
  43. BZW2 gene knockdown induces cell growth inhibition, G1 arrest and apoptosis in muscle‐invasive bladder cancers: A microarray pathway analysis
    Haifeng Gao, Guanghai Yu, Xian Zhang, Song Yu, Yu Sun, Yinghua Li · 2019 · Journal of Cellular and Molecular Medicine
  44. The auto-inhibitory state of Rho guanine nucleotide exchange factor ARHGEF5/TIM can be relieved by targeting its SH3 domain with rationally designed peptide aptamers
    Ping He, Deli Tan, Hongxiang Liu, Fenglin Lv, Wei Wu · 2015 · Biochimie
  45. Risk of Lung Cancer in Workers Exposed to Benzidine and/or Beta-Naphthylamine: A Systematic Review and Meta-Analysis
    Kimiko Tomioka, Keigo Saeki, Kenji Obayashi, Norio Kurumatani · 2016 · Journal of Epidemiology
  46. Prognostic value of miR-17-5p in cancers: a meta-analysis
    Weihao Kong, Yusheng Cheng, Hao Liang, Qiangxing Chen, Cuicui Xiao, Kun Li, Zenan Huang, Jian Zhang · 2018 · OncoTargets and Therapy
  47. High expression of ovarian cancer immunoreactive antigen domain containing 2 (OCIAD2) is associated with poor prognosis in lung adenocarcinoma
    Mai Sakashita, Shingo Sakashita, Yoshihiko Murata, Aya Shiba‐Ishii, Yunjung Kim, Ryota Matsuoka, Noriyuki Nakano, Yukio Sato, Masayuki Noguchi · 2018 · Pathology International
  48. BlackSheep: A Bioconductor and Bioconda Package for Differential Extreme Value Analysis
    L. Blumenberg, Emily A. Kawaler, M. Cornwell, Shaleigh A. Smith, K. Ruggles, D. Fenyö · 2019 · bioRxiv
  49. Extracting Pathway-level Signatures from Proteogenomic Data in Breast Cancer Using Independent Component Analysis
    Wenke Liu, Samuel Payne, Sisi Ma, David Fenyö · 2019 · Molecular & Cellular Proteomics
  50. BlackSheep: A Bioconductor and Bioconda Package for Differential Extreme Value Analysis
    Lili M. Blumenberg, Emily A. Kawaler, MacIntosh Cornwell, Shaleigh A. Smith, Kelly V. Ruggles, David Fenyö · 2021 · Journal of Proteome Research
  51. Constitutive and activation-dependent phosphorylation of lymphocyte phosphatase-associated phosphoprotein (LPAP)
    Natalia A. Kruglova, Tatiana D. Meshkova, Arthur Tigranovich Kopylov, Dmitriy V. Mazurov, Alexander V. Filatov · 2017 · PLoS ONE
  52. Endogenous arginase 2 as a potential biomarker for PEGylated arginase 1 treatment in xenograft models of squamous cell lung carcinoma
    Sze Kwan Lam, Sheng Yan, Shi Xu, U Kin-Pong, Paul Ning-Man Cheng, Jcm Ho · 2019 · Oncogenesis
  53. Targeting rho guanine nucleotide exchange factor ARHGEF5/TIM with auto-inhibitory peptides in human breast cancer
    Ou Huang, Dandan Wu, Feiyan Xie, Lili Lin, Xiaobo Wang, Min Jiang, Yafen Li, Weiguo Chen, Kunwei Shen, Xiaoqu Hu · 2015 · Amino Acids
  54. The role of ThinPrep cytology in the investigation of ki-67 index, p53 and HER-2 detection in fine-needle aspirates of breast tumors.
    Petros Konofaos, Konstantinos Kontzoglou, P. Parakeva, Ch. Kittas, Niki Margari, E. Giaxnaki, M. Pouliakis, Gregory P. Kouraklis, Petros Karakitsos · 2013 · PubMed
  55. Extensive Intratumor Proteogenomic Heterogeneity Revealed by Multiregion Sampling in High-Grade Serous Ovarian Tumor Specimens
    Allison L. Hunt, Nicholas W. Bateman, Waleed Barakat, Sasha C. Makohon‐Moore, Brian L. Hood, Kelly A. Conrads, Ming Zhou, Valerie S. Calvert, Mariaelena Pierobon, Jeremy Loffredo et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  56. Dynamic programming approach to optimal inventory processes with delay in delivery
    Richard Bellman · 1961 · Quarterly of Applied Mathematics
  57. Methodological development of dietary fiber intervention to lower colon cancer risk.
    EE Ho, Atwood, Frank L. Meyskens · 1987 · PubMed